Maternal immunization with ovalbumin prevents neonatal allergy development and up-regulates inhibitory receptor FcγRIIB expression on B cells

<p>Abstract</p> <p>Background</p> <p>Preconception allergen immunization prevents neonatal allergen sensitization in mice by a complex interaction between regulatory cells/factors and antibodies. The present study assessed the influence of maternal immunization with ova...

Full description

Bibliographic Details
Main Authors: Duarte Alberto JS, Taniguchi Eliana F, de Brito Cyro A, Fusaro Ana E, Muniz Bruno P, Victor Jefferson R, Sato Maria N
Format: Article
Language:English
Published: BMC 2010-03-01
Series:BMC Immunology
Online Access:http://www.biomedcentral.com/1471-2172/11/11
id doaj-2191f565c4834a8aa42e881375076f76
record_format Article
spelling doaj-2191f565c4834a8aa42e881375076f762020-11-25T03:43:26ZengBMCBMC Immunology1471-21722010-03-011111110.1186/1471-2172-11-11Maternal immunization with ovalbumin prevents neonatal allergy development and up-regulates inhibitory receptor FcγRIIB expression on B cellsDuarte Alberto JSTaniguchi Eliana Fde Brito Cyro AFusaro Ana EMuniz Bruno PVictor Jefferson RSato Maria N<p>Abstract</p> <p>Background</p> <p>Preconception allergen immunization prevents neonatal allergen sensitization in mice by a complex interaction between regulatory cells/factors and antibodies. The present study assessed the influence of maternal immunization with ovalbumin (OVA) on the immune response of 3 day-old and 3 week-old offspring immunized or non-immunized with OVA and evaluated the effect of IgG treatment during fetal development or neonatal period.</p> <p>Results</p> <p>Maternal immunization with OVA showed increased levels of FcγRIIb expression in splenic B cells of neonates, which were maintained for up to 3 weeks and not affected by additional postnatal OVA immunization. Maternal immunization also exerted a down-modulatory effect on both IL-4 and IFN-γ-secreting T cells and IL-4 and IL-12- secreting B cells. Furthermore, immunized neonates from immunized mothers showed a marked inhibition of antigen-specifc IgE Ab production and lowered Th2/Th1 cytokine levels, whereas displaying enhanced FcγRIIb expression on B cells. These offspring also showed reduced antigen-specific proliferative response and lowered B cell responsiveness. Moreover, <it>in vitro </it>evaluation revealed an impairment of B cell activation upon engagement of B cell antigen receptor by IgG from OVA-immunized mice. Finally, <it>in vivo </it>IgG transference during pregnancy or breastfeeding revealed that maternal Ab transference was able to increase regulatory cytokines, such as IL-10, in the prenatal stage; yet only the postnatal treatment prevented neonatal sensitization. None of the IgG treatments induced immunological changes in the offspring, as it was observed for those from OVA-immunized mothers.</p> <p>Conclusion</p> <p>Maternal immunization upregulates the inhibitory FcγRIIb expression on offspring B cells, avoiding skewed Th2 response and development of allergy. These findings contribute to the advancement of prophylactic strategies to prevent allergic diseases in early life.</p> http://www.biomedcentral.com/1471-2172/11/11
collection DOAJ
language English
format Article
sources DOAJ
author Duarte Alberto JS
Taniguchi Eliana F
de Brito Cyro A
Fusaro Ana E
Muniz Bruno P
Victor Jefferson R
Sato Maria N
spellingShingle Duarte Alberto JS
Taniguchi Eliana F
de Brito Cyro A
Fusaro Ana E
Muniz Bruno P
Victor Jefferson R
Sato Maria N
Maternal immunization with ovalbumin prevents neonatal allergy development and up-regulates inhibitory receptor FcγRIIB expression on B cells
BMC Immunology
author_facet Duarte Alberto JS
Taniguchi Eliana F
de Brito Cyro A
Fusaro Ana E
Muniz Bruno P
Victor Jefferson R
Sato Maria N
author_sort Duarte Alberto JS
title Maternal immunization with ovalbumin prevents neonatal allergy development and up-regulates inhibitory receptor FcγRIIB expression on B cells
title_short Maternal immunization with ovalbumin prevents neonatal allergy development and up-regulates inhibitory receptor FcγRIIB expression on B cells
title_full Maternal immunization with ovalbumin prevents neonatal allergy development and up-regulates inhibitory receptor FcγRIIB expression on B cells
title_fullStr Maternal immunization with ovalbumin prevents neonatal allergy development and up-regulates inhibitory receptor FcγRIIB expression on B cells
title_full_unstemmed Maternal immunization with ovalbumin prevents neonatal allergy development and up-regulates inhibitory receptor FcγRIIB expression on B cells
title_sort maternal immunization with ovalbumin prevents neonatal allergy development and up-regulates inhibitory receptor fcγriib expression on b cells
publisher BMC
series BMC Immunology
issn 1471-2172
publishDate 2010-03-01
description <p>Abstract</p> <p>Background</p> <p>Preconception allergen immunization prevents neonatal allergen sensitization in mice by a complex interaction between regulatory cells/factors and antibodies. The present study assessed the influence of maternal immunization with ovalbumin (OVA) on the immune response of 3 day-old and 3 week-old offspring immunized or non-immunized with OVA and evaluated the effect of IgG treatment during fetal development or neonatal period.</p> <p>Results</p> <p>Maternal immunization with OVA showed increased levels of FcγRIIb expression in splenic B cells of neonates, which were maintained for up to 3 weeks and not affected by additional postnatal OVA immunization. Maternal immunization also exerted a down-modulatory effect on both IL-4 and IFN-γ-secreting T cells and IL-4 and IL-12- secreting B cells. Furthermore, immunized neonates from immunized mothers showed a marked inhibition of antigen-specifc IgE Ab production and lowered Th2/Th1 cytokine levels, whereas displaying enhanced FcγRIIb expression on B cells. These offspring also showed reduced antigen-specific proliferative response and lowered B cell responsiveness. Moreover, <it>in vitro </it>evaluation revealed an impairment of B cell activation upon engagement of B cell antigen receptor by IgG from OVA-immunized mice. Finally, <it>in vivo </it>IgG transference during pregnancy or breastfeeding revealed that maternal Ab transference was able to increase regulatory cytokines, such as IL-10, in the prenatal stage; yet only the postnatal treatment prevented neonatal sensitization. None of the IgG treatments induced immunological changes in the offspring, as it was observed for those from OVA-immunized mothers.</p> <p>Conclusion</p> <p>Maternal immunization upregulates the inhibitory FcγRIIb expression on offspring B cells, avoiding skewed Th2 response and development of allergy. These findings contribute to the advancement of prophylactic strategies to prevent allergic diseases in early life.</p>
url http://www.biomedcentral.com/1471-2172/11/11
work_keys_str_mv AT duartealbertojs maternalimmunizationwithovalbuminpreventsneonatalallergydevelopmentandupregulatesinhibitoryreceptorfcgriibexpressiononbcells
AT taniguchielianaf maternalimmunizationwithovalbuminpreventsneonatalallergydevelopmentandupregulatesinhibitoryreceptorfcgriibexpressiononbcells
AT debritocyroa maternalimmunizationwithovalbuminpreventsneonatalallergydevelopmentandupregulatesinhibitoryreceptorfcgriibexpressiononbcells
AT fusaroanae maternalimmunizationwithovalbuminpreventsneonatalallergydevelopmentandupregulatesinhibitoryreceptorfcgriibexpressiononbcells
AT munizbrunop maternalimmunizationwithovalbuminpreventsneonatalallergydevelopmentandupregulatesinhibitoryreceptorfcgriibexpressiononbcells
AT victorjeffersonr maternalimmunizationwithovalbuminpreventsneonatalallergydevelopmentandupregulatesinhibitoryreceptorfcgriibexpressiononbcells
AT satomarian maternalimmunizationwithovalbuminpreventsneonatalallergydevelopmentandupregulatesinhibitoryreceptorfcgriibexpressiononbcells
_version_ 1724519985745756160